JS
Josh Schimmer Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
31%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
96%
Neutral
4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Industrials
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
Industrials
Specialty Industrial Machinery
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $10 |
184%
upside
| 3 | -0.14% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $140 |
34%
upside
| 2 | +9.5% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $100 |
566%
upside
| 2 | -29% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $25 |
295%
upside
| 1 | +31% |
0
%
| 14 Nov ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $200 |
62%
upside
| 1 | +68% |
0
%
| 6 Nov ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $95 |
4%
upside
| 1 | +31% |
0
%
| 5 Nov ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $30 |
917%
upside
| 2 | +46% |
0
%
| 31 Oct ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $110 |
50%
upside
| 2 | +25% |
0
%
| 30 Oct ‘25 5 months ago |
|
|
|
Overweight
Initiated
| $10 |
585%
upside
| 1 | +54% |
0
%
| 6 Oct ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $65 |
11%
downside
| 1 | +77% |
0
%
| 22 Sep ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| $75 |
9%
upside
| 2 | +72% |
0
%
| 8 Sep ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| – | – | 1 | +36% |
0
%
| 8 Sep ‘25 7 months ago |
|
|
|
Overweight
Reiterated
| $25 |
1%
upside
| 2 | +60% |
0
%
| 5 Sep ‘25 7 months ago |
|
|
|
Overweight
Initiated
| $25 |
73%
upside
| 1 | +107% |
0
%
| 1 Jul ‘25 9 months ago |
|
|
|
In-Line
Downgraded
| $6 |
37%
downside
| 2 | +6.2% |
0
%
| 23 Jun ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $280 |
22%
upside
| 1 | +37% |
0
%
| 2 May ‘25 11 months ago |
|